In the current issue of Roadrunner Stocks, two new BUY recommendations and two SELL recommendations have been issued. 1. The Value Portfolio is adding female medical-device manufacturer Utah Medical Products (UTMD) and selling computer network equipment manufacturer Brocade Communications (BRCD).2. The Momentum Portfolio is adding video… Read More
Jim Fink is chief investment strategist for Options for Income, Velocity Trader, and Jim Fink's Inner Circle. He has traded options for more than 30 years and generated personal profits of more than $5 million. Jim also serves as an investment analyst at Investing Daily’s flagship investing publication, Personal Finance.
Hopelessly overeducated, Jim holds a bachelor's degree from Yale University, a master's degree from Harvard's Kennedy School of Government, a law degree from Columbia University, and an MBA from the University of Virginia's Darden School of Business. For good measure, he has been a member of the Illinois and D.C. bars.
Prior to joining Investing Daily, and when not incurring student loans hiding out in academe, Jim practiced telecommunications regulatory law for nine years until he realized that he made more money trading stock options than writing briefs. After attending business school, Jim switched gears to the investment realm full-time, working for a university endowment, a private wealth management firm, an insurance and financial planning company, and as a Senior Analyst for an online investment newsletter service that encourages the wearing of funny hats.
A possible but unlikely descendant of legendary brawler and boatman Mike Fink, Jim defies his heritage, believing that investing success requires patience and analysis, not swashbuckling bravado. Besides his passion for analyzing and writing about stocks, Jim likes to hike in the desert Southwest, vacation in Las Vegas, play tennis, and feed his toddler son Cheerios.
Analyst Articles
Two things are working in the stock market right now: momentum stocks of any type and value stocks that are cheap and ripe for a takeover bid. Read More
Increased healthcare spending is a macrotrend, especially increased female healthcare spending. A small-cap company with a Buffett-style value philosophy is an exciting and profitable way to play this. Read More
China's economic weakness and currency devaluation may cause the Federal Reserve to delay its first interest-rate hike, which could spur a short-term rally into September. A subsequent washout low in October would set up the next bull run for small caps into 2016. Stay in momentum stocks until the smoke clears. Read More
In the current issue of Roadrunner Stocks, two new BUY recommendations and two SELL recommendations have been issued. 1. The Value Portfolio is adding grocery-store chain Weis Markets (WMK) and selling trucker Werner Enterprises (WERN).2. The Momentum Portfolio is adding biotech Concordia Healthcare (CXRX) and selling… Read More
Momentum stocks like China Biologic are the place to be, but also keep your eye on takeover candidates among value stocks like Lattice Semiconductor. Read More
Family-run businesses make the best investments and this grocery-store chain has the added catalyst of a retiring patriarch and takeover speculation. Read More
A Greek debt default and possible exit from the Euro has U.S. stocks in a volatile frame of mind, but stronger economic growth and a possible delay in the Fed's first rate hike should calm things down quickly. Double-bottom buy signal? Read More
In the current issue of Roadrunner Stocks, two new BUY recommendations and two SELL recommendations have been issued. 1. The Value Portfolio is adding industrial supply distributor MSC Industrial Direct (MSM) and selling real-estate financier Stewart Information Services (STC).2. The Momentum Portfolio is adding product label-maker… Read More
First-quarter GDP weakness plus merger mania equals low stock-market volatility and continued gains as investors climb a wall of worry concerning the Fed's first interest rate hike in nine years scheduled for later this autumn. Read More